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Abstract 
The immunomodulatory effects of lithium have been reported across a range of models and 
contexts. Lithium appears to have a positive effect on osteogenesis in vivo, while in vitro 
outcomes throughout the literature are varied. Tissue engineering approaches have rarely 
targeted local lithium delivery within a regenerative setting. We hypothesized that part of the 
positive effects of lithium in vivo may be due to an immunomodulatory effect manifesting in a 
local environment. To achieve a sustained lithium release from scaffold constructs, we blended 
lithium carbonate, a soluble salt of lithium, with the biomaterial polymer polycaprolactone 
(PCL). We printed constructs of PCL alone, and with 5 % (5Li) and 10 % (10Li) lithium 
carbonate. Mechanical testing revealed that mechanical properties were largely retained with 
lithium carbonate incorporation, and we measured a consistent release of the ion over a 7-day 
period. The efficacy of our construct system was then assessed using a primary mouse 
macrophage culture, and a differentiated osteoclast culture. We found that the lithium released 
from constructs had a great effect on macrophage polarization, resulting in pronounced 
upregulation of immunomodulatory (M2) genes, and a decrease in pro-inflammatory (M1) 
genes. This was reflected in cytokine expression, and illustrated through immunofluorescent 
staining. Osteoclast activity was greatly suppressed by the lithium incorporation, with a marked 
effect on gene expression and actin ring formation. Our work demonstrated an effective system 
for local lithium delivery, confirmed the pronounced effects that lithium has on macrophage 
and osteoclast response, and sets the stage for further innovations in ion release for targeted 
tissue engineering. 
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1. Introduction 
Tissue engineering involves the formation of biodegradable and structurally supportive 
biomaterial scaffold constructs to regenerate damaged tissues or organs [1]. The field spans 
multiple organ systems and targets the treatment of a multitude of conditions. A prominent area 
of tissue engineering research is that of bone regeneration, where biomaterials such as 
polycaprolactone (PCL), a biodegradable aliphatic thermoplastic polyester, are used to form 
scaffolds to support osteogenesis [1, 2]. PCL is an easily-workable material, and as such is well 
suited to 3-dimensional (3D) printing, where a layer-by-layer printing of thin filaments is used 
to form a porous scaffold. While PCL is not ideal for significant load-bearing applications, 
porous PCL scaffolds are able to maintain their shape in low-load bone defects and provide a 
linked porous structure, allowing osteoblast migration and tissue growth [2, 3]. 
As with the implantation of any biomaterial, however, the surgical insertion of a PCL scaffold 
is met with an inflammatory response from the host. After initial protein adsorption on the 
implant surface, monocytes migrate to the defect area, where they differentiate into 
macrophages and bind to the implant surface proteins through integrin-modulated mechanisms 
[4]. In addition to their role in host defense and inflammation, macrophages have also been 
implicated in tissue remodeling and various metabolic functions. As such, an environment that 
encourages healing may be established by taking advantage of these diverse roles of 
macrophages [5]. Indeed, the modulation of macrophage response has been widely identified 
as a means through which biomaterial integration and healing response can be improved [5-8]. 
Many tissue engineering strategies aim to enhance healing through the release of bioactive 
growth factors from scaffolds of varying composition [9-12]. While reasonably effective, 
growth factors are very expensive, are difficult to sterilize due to their thermal instability, have 
a short half-life in situ, and have undesirable effects at high doses.  
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Lithium carbonate (Li2CO3) is available as an orally-administered drug used in the treatment 
of bipolar disorder [13-15]. In this application, dosages around 300 mg per day are common, 
with regular blood tests and symptom tracking used to moderate dose. Acute toxicity is 
temporary if at all encountered, and the drug is considered safe when administered in a 
controlled manner. Lithium (Li) is systemically present in its ionic form Li+, where it primarily 
acts as an inhibitor of intracellular GSK3β function [16]. This results in the impairment of β-
catenin ubiquination and subsequent destruction, promoting the Wnt signaling pathway. The 
large-scale manifestation of this effect appears diverse, with Li+ administration resulting in 
favorable immunomodulation [17], improved osteogenesis in vivo [18], and cementogenesis in 
vitro and in vivo [16, 19]. These combined effects make lithium carbonate a potentially ideal 
drug for use in bone tissue engineering, as well as in the treatment of chronic inflammatory 
degenerative diseases such as periodontitis or arthritis. 
Previous prominent work from our group and collaborators has supported lithium delivery as 
a method for significantly enhancing bone and periodontal regeneration through the above 
described mechanism [19]. However, bolus lithium administration and the lack of physical 
support at the defect site limited the outcomes of this approach. Further, lithium has generally 
failed to demonstrate consistently positive effects on osteogenic or cementogenic 
differentiation in vitro, with contrasting results in the literature [20-23], while it has been 
consistently found to have positive effects when applied in vivo [18, 20, 24]. This suggests that 
some of the positive effects of lithium on tissue regeneration may be due to additional indirect 
effects that do not influence cultured resident cells of mesenchymal origin, such as osteoblasts 
or periodontal ligament cells. 
This study proposes an alternate approach to conventional tissue engineering scaffold strategies 
using cell and growth factor therapies. The objective is to take advantage of the 
immunomodulatory effects of an established drug, lithium carbonate, by incorporating it within 
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the thermoplastic biomaterial polycaprolactone (PCL), for the formation of bioactive 
immunomodulatory scaffolds. Finding positive immunomodulatory effects from an in vitro 
lithium scaffold system supports the notion that the reported in vivo outcomes may be 
manifesting through effects on immune-inflammatory system rather than resident 
mesenchymal cells. This will in turn support the use of local lithium administration for the 
treatment of bone defects, especially in inflammatory environments such as those encountered 
in arthritis and periodontitis. 
The specific aim is to assess the effects of tissue engineering scaffolds containing lithium on 
macrophage polarization. To this end, we herein describe the preparation of 3D printed 
scaffolds made of PCL containing 5 and 10 wt. % (henceforth %) Li2CO3. We verify the 
release of the lithium ion into cell culture media, subject the constructs to mechanical testing 
and other characterizations, and undertake cell culture with primary mouse macrophages and 
osteoclasts to assess the immunomodulatory effects of the compound. 
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2. Materials and methods 
2.1. Composite material and scaffold preparation 
Lithium carbonate (Sigma Aldrich, Merck KGaA, Darmstadt, Germany) powder was dispersed 
in a chloroform (Merck KGaA, Darmstadt, Germany) solution, into which polycaprolactone 
(PCL) of a 45 kDa Mn (Sigma) was added to a total of 10 % solids. Lithium carbonate 
concentrations of 5 and 10 % in PCL were produced. The mixture was stirred at 40 °C in a 
glass beaker inside a fume hood for 30 – 60 min until the viscosity increased such that stirring 
became impaired. The solutions were then cast directly into 140 mm glass petri dishes and 
dried in a vacuum desiccator for 48 h. Study groups comprised PCL-only (PCL), 5 % Li2CO3 
(5Li), and 10 % Li2CO3 (10Li). 
Scaffolds were printed using a GeSiM BioScaffolder 3.1 (GeSiM mbH, Großerkmannsdorf, 
Germany) with a TECDIA Arque 400 µm inner diameter precision dispensing needle 
(TECDIA Inc, Campbell, CA, USA). Printing was performed at 85 °C, with 520 kPa extrusion 
air pressure, and a stage speed of 2 mm·s-1. Layers were printed at 750 µm filament spacing, 
320 µm layer height, a 90 ° angle of rotation between subsequent layers, and a total of 6 layers 
per construct (~2 mm total construct height). Prior to use, all scaffolds were cut to 5×5 mm 
rectangular prisms and were immersed in 5 M NaOH for 1 h at 37 °C to improve surface 
hydrophilicity and roughness. 
2.2. Mechanical testing 
Scaffold mechanical properties were assessed through compressive testing as per ISO 604-1, 
where possible. Testing was performed on an Instron MicroTester 5848 with a 500 N load cell 
and a 1 mm·min-1 crosshead speed, to a total strain of 15 %. Data were processed, with 
compressive elastic modulus taken as the slope of the stress/strain curve over 4 – 6 % strain, 
and stress at 10 % strain was taken directly from the data as per ISO 604-1 recommendations 
for data analysis where a yield point is difficult to isolate. 
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2.3.  Scanning electron microscopy (SEM) imaging 
Scaffolds were immersed in liquid N2 and cut with a scalpel to achieve clean cross-sectional 
cuts. Representative samples from the three experimental groups (PCL, 5Li, 10Li) were imaged 
using a Phenom™ G2 Pro (Phenom World, Thermo Fisher Scientific, ATA Scientific, NSW, 
Australia) desktop scanning electron microscope (SEM). Images of the surface and cross-
sections of filaments were taken, using optical microscopy, as well as secondary electron and 
backscatter electron detection. 
2.4. Ion release and pH change 
As lithium carbonate releases lithium cations and the carbonate anion upon dissolution, lithium 
ion release, and the pH of cell culture media were assessed over a week of scaffold immersion. 
Since typically media changes are done every 2 – 3 days during cell culture, longer time points 
were not studied, with the 7-day time point used for completeness. Ion release was assayed 
using inductively-coupled plasma optical emission spectroscopy (ICP-OES; Optima 8300, 
Perkin Elmer, MA, USA) over days 1, 2, 4, 5 and 7 of immersion in a 37 °C humidified 
atmosphere with 5 % CO2 in air. 
2.5. Cell culture 
Primary murine bone marrow-derived macrophages (BMM) were isolated from 5-7 week-old 
C57BL/6 black mice (Animal Resources Centre, Australia) as previously described [25]. 
Approval for all procedures was obtained from the Griffith University Animal Ethics 
Committee (DOH/02/16/AEC). The femurs and tibias of mice were aseptically isolated and 
removed from the surrounding tissues. The bone edges were cut off and the marrow cavity was 
ﬂushed with high-glucose alpha minimum essential medium (MEM; Thermo Fisher Scientific), 
by slowly injecting one end of the bone using a sterile needle. Red blood cell (RBC) lysis buffer 
was used to remove RBCs. The bone marrow cells (BMCs) were collected in the MEM, and 
after washing, the cells were cultured in 100 mm culture dishes containing MEM, 10 % fetal 
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bovine serum (FBS; Thermo Fisher Scientific) and 1× penicillin/streptomycin solution 
(Thermo Fisher Scientific), for 1 day at 37 °C in a humidiﬁed atmosphere of 5 % CO2 in air, 
and 10 ng·mL-1 macrophage colony-stimulating factor (M-CSF) (Peprotech, USA). On day 2, 
adherent cells were removed and the non-adherent cells were collected and washed with 1× 
phosphate-buffered saline (PBS; Thermo Fisher Scientific). After washing, cells were cultured 
in the same media with 30 ng·mL-1 M-CSF for 5 days, prior to their use in the study.  
2.6. Scaffold sterilization 
PCL, 5Li, and 10Li scaffolds were placed inside individual wells of a 48-well plate inside a 
Class II biological safety cabinet (BSC), and each well was filled with 500 µL of 70 % ethanol. 
The scaffolds were then subjected to 20 min ultraviolet (UV) irradiation, as per the standard 
BSC sterilization protocol. After sterilization, scaffolds were moved from the ethanol solution 
into new, sterile 48-well plates, and dried overnight inside the running BSC. Scaffolds were 
thereafter used for culture. 
2.7. Cell proliferation assay 
BMM cells were seeded onto scaffolds in 48-well plates (2.0×104 cells per well) and incubated 
for 3 h, and 1, 4, and 7 days, respectively. At each time point, specimens were transferred to 
new well plates, where they were rinsed with 1× PBS. A cell counting kit (CCK-8, Dojindo, 
Japan) was used to assess proliferation, according to the manufacturer’s instructions. Briefly, 
after a 2 h incubation with 10 % of the media volume comprising the CCK-8 reagent (e.g. 50 
µL CCK-8 reagent in 500 µL media volume) at 37 °C, 200 µL of the solution was carefully 
transferred from each sample to a 96-well plate. The optical density (OD) was measured using 
a microplate reader, at a wavelength of 450 nm (FLUOstar Optima, BMG LABTECH, Thermo 
Fisher Scientific). 
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2.8. Live/dead assay 
Cell viability was assessed by live/dead staining. BMM cells were seeded at a density of 
5.0×104 cells per well on 3D scaffolds and a tissue culture plate (TCP) control, within 48 well 
plates. After 24 h and 48 h of culture, cells were rinsed with PBS and incubated with a live/dead 
stain (fluorescein diacetate (FDA) and propidium iodide (PI)) for 30 min at room temperature 
(RT). Viable cells (green) and dead cells (red) were imaged under a confocal laser scanning 
microscope (CLSM, A1R+, Nikon, Japan). 
2.9. Immunofluorescent staining and imaging 
Immunofluorescent staining was performed to evaluate the local expression of CCR7 (M1 
marker) and the mannose receptor CD206 (M2 marker). The BMM cells were seeded at a 
density of 5.0×104 per well on the scaffolds and TCP controls, and cultured for 1, 4, and 7 days. 
These were then fixed with 3.7 % paraformaldehyde (PFA) for 20 min and permeabilized with 
0.05 % Triton X-100 (Thermo Fisher Scientific) for 10 min. Cells were stained using primary 
antibodies for CCR7 (Abcam, Cambridge, MA, USA) and CD206 (Santa Cruz Biotechnology 
Inc, California, USA) overnight, then incubated with secondary antibodies Alexa Fluor® 568 
goat anti-rabbit IgG (Abcam) and rabbit anti-goat IgG-FITC (Santa Cruz Biotechnology Inc) 
for 1 h. After washing, the samples were incubated with 4,6-diamidino-2-phenylindole 
dihydrochloride (DAPI; Invitrogen) for 10 min, and observed under a confocal laser scanning 
microscope (CLSM, A1R+, Nikon, Japan). 
2.10. Enzyme-linked immunosorbent assay (ELISA) 
The secretion of inflammatory cytokines (proinflammatory IL-1β and anti-inflammatory IL-
10) was measured in media using a commercially available DuoSet ELISA kit (R&D systems, 
Minneapolis, MN, USA). BMM cells were cultured at a density of 5.0×104 cells per well on 
TCP and 3D scaffolds in 48-well culture plates. At 1, 4, 7 days of culture, 100 μL of the culture 
media was collected and incubated in plates coated with IL-1β and IL-10 antibodies for 2 h, at 
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RT. The protein levels of the secreted molecules were measured with a microplate reader at 
450 nm according to the manufacturer’s instructions.  
2.11. RNA isolation and quantitative real-time PCR (qRT-PCR) 
Gene expression was assessed at days 1, 4, and 7 to assess M1 and M2 macrophage phenotype. 
Total RNA was extracted using TRIzol reagent (Invitrogen, USA) and an RNeasy Plus Mini 
Kit (Qiagen, CA, USA) according to the manufacturer’s instructions. Then, SuperScript™ IV 
VILO™ Master Mix (Invitrogen, USA) was used to prepare complementary DNA (cDNA) 
according to the manufacturer’s protocols. Oligonucleotide primers were used to assess the M2 
markers CD163 and arginase 1 (Arg 1), and M1 markers CD86 and inducible nitric oxide 
synthase (iNOS), as shown in Table 1. Quantitative real-time PCR (qRT-PCR) analysis was 
performed using KAPA SYBR FAST Master Mix (Kapa Biosystems, Boston, MA) and 
reactions (LightCycler 480 Real-Time PCR System, Roche, USA) were run using the following 
parameters: denaturation at 95 °C for 30 s, then 40 cycles of amplification (95 °C for 10 s, 57-
60 °C for 20 s and 72 °C for 1 s). Quantification of gene expression was calculated using the 
2-ΔΔCt method. The expression of the targeted genes was normalized using the geometric 
average of the house-keeping gene (GAPDH). All results were confirmed by repeating the 
experiment in triplicate. The fold change from TCP samples at 1 day was set at 1-fold and the 
ratio of the normalized fold change was calculated. 
2.12. Osteoclast differentiation 
For osteoclast differentiation, primary cultures of BMMs were used. The BMM cells were 
prepared as described above. To stimulate osteoclast differentiation, BMMs were then seeded 
at a density of 5×104 cells on scaffolds in a 48-well culture plate, and were cultured in MEM 
supplemented with 10 % FBS and 1 % P/S. This was also supplemented with RANKL (100 
ng·mL-1) and M-CSF (30 ng·mL-1) at 37 °C under 5 % CO2, for a 6-day culture. Cells were 
then fixed in 3.7 % PFA for 20 min and permeabilized with 0.05 % Triton X-100 for 10 min. 
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After washing, the cells were stained with rhodamine-conjugated phalloidin (Invitrogen, USA) 
for 30 min. Actin ring formation was observed using a Zeiss Axiolab fluorescence microscope. 
To confirm gene expression for osteoclast differentiation, qRT-PCR was also performed at 6 
days. Oligonucleotide primers for the osteoclast differentiation markers tartrate-resistant acid 
phosphatase (TRAP), osteoclast associated immunoglobulin-like receptor (OSCAR), nuclear 
factor of activated T-cells 1 (NFATc1), and c-FOS are shown in Table 1.  Quantification of 
gene expression was also calculated using the 2-ΔΔCt method. The expression of the targeted 
genes was normalized using the geometric average of house-keeping genes (GAPDH). All 
results were confirmed by repeating the experiment in triplicate. The ratio of the normalized 
fold change was calculated relative to the control TCP samples. 
2.13. Data analysis 
Each experiment was performed at least three times. All quantitative data was expressed as 
mean ± standard deviation (SD). One way analysis of variance (ANOVA) was used to test the 
null hypothesis, that the group means were equal, against an alternative hypothesis, that at least 
two of the group means were different, at an α = 0.05 significance level (SPSS 24.0, IBM 
Corporation, NY, USA). When the p-value resulting from the initial ANOVA model was 
determined to be <0.05, multiple comparisons were made between group means with Tukey’s 
post hoc test. 
3. Results 
3.1. Scaffold Characterization 
PCL, 5Li and 10Li constructs were subjected to uniaxial compressive testing to determine 
elastic modulus and stress at 10 % strain. Elastic modulus was 33.9, 31.7, and 30.7 MPa for 
the three groups, respectively, with no significant differences found between scaffold types. 
Stress at 10 % strain was 2.7, 2.6, and 2.1 MPa for PCL, 5Li, and 10Li, respectively, with 10Li 
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found to be significantly lower than both of the other groups, and no difference found between 
PCL and 5Li (Figure 1 (a)-(b)). 
 
Figure 1. Mechanical characterization, lithium ion elution, and pH change of scaffold groups. 
Elastic modulus (a) and stress at 10 % strain (b) were derived from test data, n = 5 for each group, * indicates significance 
against PCL. In this case, 10Li was also significantly lower than 5Li for stress at 10 % strain. Lithium ion release into MEM 
(c) and the pH of the MEM (d), measured up to 7 days. Individual replicates (n = 3) are shown, with lines passing through the 
mean at each time point. 
Optical microscopy was used to illustrate the overall scaffold morphology (Figure 2 (a), (e), 
(i); scale bar 1 mm). Scanning electron microscopy (SEM) was performed on both the top and 
cross-section of fibers from the three groups to show the filament morphology (top view of 
filaments, secondary electron emission; Figure 2 (b), (f), (j)) as well as the appearance of the 
fiber cross-sections (secondary electron emission; Figure 2 (c), (g), (k), backscattered electron 
emission; Figure 2 (d), (h), (l)). No particles were visible at the surface of the fibers. The 
presence of lithium carbonate particles was clearly visible in fiber cross-sections under 
backscattered electron emission imaging, with particles around 100 µm observed in both 5Li 
and 10Li groups (Figure 2 (h), (l), scale bar 100 µm). 
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Figure 2. Scanning electron microscopy images illustrating the overall scaffolds, as well as scaffold filament and cross-
sectional morphology. 
Images were taken of the sides of the overall scaffolds ((a), (e), (i), filaments ((b), (f), (j)) using secondary electron emission, 
and of the fiber cross-sections using secondary electron emission ((c), (g), (k)) and backscattered electron emission ((d), (h), 
(l)). Optical microscopy is shown at 40× magnification with a 1 mm scale bar, and SEM images are at 500× magnification, 
with the scale bar indicating 100 µm. 
Lithium ion release into MEM was measured using ICP-OES, with the pH of the solutions also 
tested at each time point (Figure 1 (c)-(d)). ICP-OES and pH measurements indicated a 
cumulative release of up to 10 mM Li+ in 5Li and 20 mM Li+ in 10Li by day 7, with pH reaching 
around 7.7 and 8.3 for the groups, respectively. While these data were measured over single 
immersion periods of the prescribed durations, it should be noted that during the cell culture 
assays, media was changed every 48-72 h. The peak values observed in these data are hence 
higher than what was present during culture, where each media change would reset the ion 
concentration to zero and reintroduce a balanced pH of 7.4. Overall, a sustained release of 
lithium was observed, with the profile illustrated by both pH and ICP-OES data. 
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3.2. Macrophage proliferation and viability 
Primary mouse macrophages were found to proliferate in all groups (Figure 3), however, 
reduced proliferation was detected in both of the 5Li and 10Li groups at days 1, 4, and 7. The 
5Li and 10Li conditions showed a similar response on day 1 and 4, with both exhibiting 
significantly lower cell numbers than PCL. By day 7, both groups were again significantly 
lower than PCL, with 10Li also significantly lower than 5Li. 
Viability was qualitatively assessed using FDA and PI staining after 24 and 48 h of scaffold 
culture (Figure 4). Very high cell viability was observed across all groups and both time points. 
 
Figure 3. Proliferation of macrophages over 7 days of culture on scaffolds. 
Data are normalized to PCL seeding value, with individual replicates shown for each group, as well as mean ± SD. n = 3 for 
each group, * indicates significance against PCL unless otherwise signed. 
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Figure 4. Viability of macrophages over 24 and 48 h of culture on scaffolds. 
Live/dead staining using FDA and PI performed on the three groups over 24 h ((a), (c), (e)), and 48 h ((b), (d), (f)) of culture. 
PCL ((a), (b)), 5Li ((c), (d)), and 10Li ((e), (f)) are shown, with the scale bar indicating 200 µm. 
 
3.3. Cytokine secretion and gene expression 
CLSM imaging was used to assess macrophage polarization on days 1, 4, and 7 of culture 
(Figure 5), using M1 marker (CCR7, red), M2 marker (CD206, green) and nuclei (DAPI, blue) 
staining. While limited polarization was observed on days 1 and 4, day 7 illustrated a more 
obvious difference between the groups, with PCL (Figure 5 (c)) showing predominantly M1 
staining, and 5Li (Figure 5 (f)) and 10Li (Figure 5 (i)) both showing prominent M2 staining. 
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Figure 5. Immunofluorescence of M1/M2 macrophage markers over 7 days of culture on scaffolds. 
Immunofluorescent staining of nuclei (DAPI, blue), and M1 (CCR7, red) and M2 (CD206, green) markers imaged using 
confocal laser scanning microscopy on day 1 ((a), (d), (g)), day 4 ((b), (e), (h)), and day 7 ((c), (f), (i)). Inset panels on A, B, 
and C illustrate tissue culture plastic controls. By day 7, clear M1 staining is observable in PCL (c), with M2 staining 
dominating 5Li (f) and 10Li (i) samples. Scale bar indicates 200 µm. 
Cytokine secretion of IL-1β and IL-10 was tested using ELISA, and normalized to DNA 
content as quantified via PicoGreen (Figure 6). The assay was performed for a tissue culture 
plastic control (TCP), and the three scaffold groups on days 1, 4, and 7 of culture. While 
minimal IL-1β secretion occurred in the TCP group, pronounced pro-inflammatory response 
was found in the PCL group on days 4 and 7 with minimal IL-1β secretion observed in the 5Li 
and 10Li groups (Figure 6 (a)). Conversely, while IL-10 secretion was again very low on TCP 
over the entire period, PCL had a significantly greater level of secretion, which was 
significantly exceeded by 10Li on days 1 and 4, and both 5Li and 10Li on day 7 (Figure 6 (b)). 
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Figure 6. Cytokine secretion in media from macrophages over 7 days on scaffolds. 
Enzyme-linked immunosorbent assay results for interleukin 1β (pro-inflammatory; (a)) and interleukin 10 (anti-inflammatory; 
(b)) over 1, 4, and 7 days of culture. Individual replicates (n = 3) are shown, with mean ± SD included, and * indicating 
significant difference to the PCL group. An additional tissue culture plastic (TCP) control was also used. 
Gene expression of M2-related genes ARG1 and CD168, and M1-related genes iNOS and CD86 
was tested on days 1, 4, and 7 of culture for the TCP control and the three scaffold groups 
(Figure 7). Upregulation of ARG1 (Figure 7 (a)) was observed by day 1 in 5Li, and in both 
5Li and 10Li on days 4 and 7. Expression of CD163 (Figure 7 (b)) was also upregulated in 
both 5Li and 10Li on days 1 and 7, with no significant difference measured on day 4 between 
any group. Expression of iNOS (Figure 7 (c)) was significantly higher in PCL than TCP and 
10Li on day 1, and significantly higher than all groups on days 4 and 7, reaching a peak of 2.5-
fold increase compared to the TCP control by day 7. Minimal difference was measured in CD86 
expression (Figure 7 (d)) between the groups, with all three of the scaffold groups 
demonstrating an elevation to significantly higher levels than TCP on day 7. 
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Figure 7. Gene expression of M1/M2-relevant genes over 7 days of culture on scaffolds. 
Quantitative real-time polymerase chain reaction for M2 genes ARG1 (a) and CD163 (b), and M1 genes iNOS (c) and CD86 
(d) was performed for days 1, 4, and 7 of macrophage culture on scaffolds. Individual replicates (n = 3) are shown, with mean 
± SD included, and * indicating significant difference to the PCL group. An additional tissue culture plastic (TCP) control was 
also used. 
3.4. Osteoclast differentiation 
Osteoclast differentiation was induced over a 6-day period, with assays conducted on the final 
day of culture. CLSM imaging of the three scaffold groups (Figure 8 (a)-(c)) indicated 
pronounced actin ring staining in the PCL group (Figure 8 (a)), with largely diminished 
staining in 5Li (Figure 8 (b)) and 10Li (Figure 8 (c)). 
Assessment of osteoclast-relevant genes TRAP, OSCAR, NFATc1, and c-FOS was performed 
on day 6 of culture (Figure 8 (d)-(g)), and revealed a significant inhibition of osteoclast 
differentiation in the presence of the lithium experimental groups. No difference was detected 
between the TCP positive control and PCL for any gene, while both 5Li and 10Li showed 
significantly reduced expression for all four genes, with 10Li also being significantly lower 
than 5Li for OSCAR expression (Figure 8 (e)). 
Page 18 of 29AUTHOR SUBMITTED MANUSCRIPT - BMM-102426.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
nu
scr
ipt
Page 19 of 29 
 
Figure 8. Immunofluorescence and gene expression of osteoclasts and osteoclastic genes after induction. 
Immunofluorescent staining of nuclei (DAPI, blue), and actin (rhodamine-conjugated phalloidin, red) imaged using confocal 
laser scanning microscopy on day 6 of osteoclastic induction. Clear actin ring staining is observable on PCL scaffolds ((a), 
arrows indicating prominent osteoclasts), with a diminished stain on 5Li (b) and 10Li (c) groups. Scale bar indicates 200 µm. 
Quantitative real-time polymerase chain reaction for osteoclastic genes TRAP (d), OSCAR (e), NFATc1 (f) and c-FOS (g) was 
performed after 6 days of osteoclastic induction on scaffolds groups. Individual replicates (n = 3) are shown, with mean ± SD 
included, and * indicating significant difference to the PCL group, and additional differences between 5Li and 10Li 
individually marked. A positive tissue culture plastic control (+Ctrl) was also used. 
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4. Discussion 
This study’s aims were to assess the feasibility of our PCL-Li2CO3 fabrication method, with 
the leaching of lithium salts through diffusion providing a gradual ion release, and to test the 
hypothesis that lithium released in this way would have an immunomodulatory effect on 
macrophage and osteoclast responses. With the application of this work being in the tissue 
engineering of bone and/or regeneration of tissues in chronic inflammatory conditions such as 
arthritis and periodontitis, it is postulated that this fabrication method can provide a cost-
effective and highly customizable approach to the delivery of bioactive ions in situ. 
Mechanical testing of the three groups indicated that the material properties were largely 
maintained with the incorporation of lithium carbonate. Modest decreases were, however, 
observed with the addition of the lithium, with 10Li showing a statistically significantly 
decreased stress at 10 % strain. This is because unlike traditional composite blends, where 
typically mechanically robust bioactive glass [26-28] or ceramic [29-31] particles are added to 
PCL, the lithium carbonate used in this work is not a mechanically stable compound, but simply 
a salt crystal powder. As such, we did not observe characteristic increases in elastic modulus 
due to matrix reinforcement, and instead observed decreases in all mechanical properties 
through the incorporation of the salts. However, the overall change in mechanical properties 
was not pronounced, and the structures maintain properties comparable to plain PCL in the 
context of bone and related tissue engineering applications. 
SEM imaging was used to assess the morphology of the scaffold filaments and the lithium 
carbonate particles present in the 5Li and 10Li groups. Particle incorporation appeared as 
expected, with homogeneous distribution throughout the cross-sections of particles and limited 
particle presence on the surface of the filaments. This central localization of particles is a result 
of the high pressures and needle geometries used in 3D printing, where the molten polymer is 
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exposed to high shear stress along the inner surface of the needle and hence the particles remain 
suspended within the bulk. 
Macrophage polarization appeared to be dramatically affected by the lithium released from 
scaffolds, with proliferation, immunofluorescence, ELISA, and qRT-PCR data all 
demonstrating pronounced effects. Immunofluorescent staining was strong for the M1 
phenotype in PCL, and the M2 phenotype in 5Li and 10Li by day 7, with earlier time points 
failing to demonstrate polarization along either phenotype. These data were corroborated by 
ELISA, which confirmed the suppression of pro-inflammatory IL-1β secretion by lithium, with 
PCL showing a significantly higher amount of the cytokine by day 7, and also through the 
secretion of anti-inflammatory IL-10, with 5Li and 10Li groups inducing a greatly increased 
release of this cytokine. Gene expression further supported this trend, with ARG1 and CD163 
expression increased, and iNOS and CD86 expression decreased under the influence of lithium 
release. Macrophage proliferation was somewhat reduced in the lithium groups, which is 
consistent with previous work on macrophage response to lithium [17]. While lithium has been 
universally described to be affecting physiological changes through its suppression of GSK3β 
[16, 32, 33], its immunomodulatory anti-inflammatory effects have been alternately attributed 
to the activation of transcription factor CREB [33]. This occurs through the upstream 
stimulation of Tpl2, a MAP3K and activator of the MAPK/ERK pathway, leading to CREB 
promotion [33]. The activation of Tpl2 is purportedly through degradation of p105, a NF-κB 
precursor protein known to inhibit Tpl2 through complexation [33]. This also subsequently 
results in a reduction of NF-κB1 p50, which along with increases in the RelA inhibitor IκBα, 
further indirectly inhibits NF-κB TLR4 activation signals. TLR4 is known to respond to 
proinflammatory stresses, such as stimulation with lipopolysaccharide (LPS; also known as 
endotoxin), a bacterial cell wall derivative known to induce septic shock and used to study 
states of inflammation [33]. As such, lithium appears to modulate inflammation through both 
Page 21 of 29 AUTHOR SUBMITTED MANUSCRIPT - BMM-102426.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
an
us
cri
pt
Page 22 of 29 
a direct effect on p105 degradation, and an indirect suppression of LPS-mediated 
proinflammatory response, which also results in a promotion of macrophage apoptosis [33]. In 
our case, the apparent decrease in macrophage proliferation was not a result of reduced viability 
at early time points, with cell numbers observed to be maintained over 24 and 48 h. Indeed, the 
levels of lithium present in the MEM by 48 h (each media change of ~5 mM 5Li and ~10 mM 
10Li) were within previously reported cytocompatible limits [19, 34]. The reduction in 
macrophage proliferation that we observed in the present study may indeed be a result of a 
delayed macrophage apoptosis, or a suppression of proliferation due to cell 
differentiation/maturation. It should be noted that the release of lithium carbonate in this model 
is a result of the gradual diffusion of water through the PCL bulk. When the water molecules 
reach the lithium carbonate, which has a limited solubility in water, they are able to partially 
dissolve the salt, causing a slow release of lithium and carbonate ions into the solution.  
Osteoclast differentiation was tested using immunofluorescent staining of nuclei and actin 
(DAPI/phalloidin), and gene expression of TRAP, OSCAR, NFATc1, and c-FOS. A clear trend 
was again observed in this case, with actin ring hypertrophy failing to manifest in the lithium 
scaffolds, and an overall suppression of the expression of osteoclastogenic genes. This 
phenomenon has been previously shown in the literature, where osteoclastogenesis caused by 
proinflammatory titanium particles was also successfully attenuated through lithium treatment, 
with the effect similarly attributed to inhibition of the NF-κB pathway [35]. The authors also 
observed a similar cytokine profile to our work [35], although this has not been universally 
reported throughout the literature [32, 33, 35-38]. The effects of lithium are not completely 
understood, and the range of responses that have been observed throughout the literature 
suggest that the ion has significantly different effects depending on the tissue or cell type to 
which it is applied. Interestingly, some studies have even found a proinflammatory effect of 
lithium exposure, with post-transcriptional upregulation of tumor necrosis factor alpha (TNFα) 
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[37, 38], and signaling occurring at different levels depending on the presence or absence of 
TLR2/3 stimulation [37].  
Conflicting data between in vitro and in vivo experiments has further complicated this issue 
[16, 20, 21, 23, 34]. In the literature, the effect of lithium-supplemented culture of BMSCs 
[34], pre-osteoblasts [20], and cementoblasts [16] has varied proliferation outcomes, with both 
increased and decreased responses reported. While we demonstrated clear effects of lithium on 
macrophage response using our system, the mode of action of lithium in vivo is not well 
characterized across the literature, despite studies assessing lithium immunomodulation 
spanning the last 40 years [39-41]. 
An example of disparate physiological responses is evidenced through the work of Knijff et al. 
[42], who studied monocytes from patients undergoing lithium treatment for bipolar disorder, 
patients using an alternate treatment, and healthy control subjects. They assessed the response 
of the cells ex vivo and in vitro via exposure to both LPS and various concentrations of lithium 
chloride. They focused their analysis on the secretion of IL-1β and IL-6, and found that all 
groups had normal baseline levels of these markers irrespective of their condition or ongoing 
treatment. Interestingly, lithium exposure had no noticeable effect on cytokine secretion in this 
idle baseline state. When LPS was used to promote inflammation, observed through a marked 
increase in cytokine production, the lithium treatment provided a dose-responsive decrease in 
IL-1β in all patients and in both IL-1β and IL-6 in bipolar patients. Significant suppression of 
the proinflammatory markers was observed at 5 mM Li, and no monocyte toxicity was found 
in any condition. However, the authors also found a slightly different response from monocytes 
ex vivo, with the lithium treatment of LPS-induced inflammation resulting in the restoration of 
a physiological IL-1β/IL-6 ratio through an increase in IL-1β and reduction in IL-6 levels. They 
suggest that the reason for this discrepancy, also observed in a slightly different context by 
Boufidou et al. [43], is that immune cells are typically exposed to different concentrations and 
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durations of lithium treatment when systemic administration is used. This may result in the 
stimulation of various mechanisms, resulting in a variety of modes of action. Further, the modes 
of action of lithium overall are not completely characterized, with other mechanisms, including 
neuro-endocrine modulation, having the potential to influence receptor signaling or affect ion 
channel function [17, 42]. 
Our application of lithium to the local modulation of macrophage response is somewhat distant 
from systemic administration for bipolar treatment. However, lithium has shown positive 
effects on macrophage and osteoclast response, osteogenesis, and cementogenesis throughout 
the literature, which has been observed to manifest under both systemic and local 
administration [18, 24, 33-35, 44-46]. The use of lithium as a locally delivered treatment for 
inflammatory and degenerative disorders such as periodontitis, arthritis and osteoporosis has 
been preliminarily trialed, but not comprehensively tested in clinically relevant systems or 
timeframes. As such, further investigation of the effects of lithium for bone regeneration and 
the treatment of chronic inflammatory conditions is required to establish its viability as a 
clinical solution. 
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5. Conclusion 
Our work confirmed that the incorporation of low-solubility salts in a polymer prior to 3D 
printing is an effective method for the creation of a composite implant that exhibits delayed 
leaching of bioactive ions. This approach may be further modulated by using variable solubility 
salts; for example, lithium fluoride would provide a pronounced decrease in lithium ion release 
rate due to its limited solubility compared with lithium carbonate. 
We further showed that lithium released from our scaffold system has a desired 
immunomodulatory effect on macrophages and osteoclasts, in alignment with previous 
literature. We aim to build on this data through evaluating these effects in vivo, studying both 
the direct immunomodulatory effects of lithium, as well as its effects on the regeneration of 
bone and periodontal tissues. Local delivery of lithium, a cost-effective and safe compound, 
would constitute an ideal approach for future therapies in regenerative medicine. 
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Table 1. Primer sequences for analyzed genes. 
Gene Primer sequence (5’3’) 
GAPDH 
Sense: GGC ATT GCT CTC AAT GAC AA 
Antisense: TGT GAG GGA GAT GCT CAG TG 
Arg1 
Sense: GTG AAG AAC CCA CGG TCT GT  
Antisense: GCC AGA GAT GCT TCC AAC TG 
CD163 
Sense: CCT GGA TCA TCT GTG ACA ACA 
Antisense: TCC ACA CGT CCA GAA CAG TC 
iNOS 
Sense: CCC TTC AAT GGT TGG TAC ATG G 
Antisense: ACA TTG ATC TCC GTG ACA GCC 
CD86 
Sense: GAG CGG GAT AGT AAC GCT GA 
Antisense: GGC TCT CAC TGC CTT CAC TC 
TRAP 
Sense: CTG GAG TGC ACG ATG CCA GCG ACA 
Antisense: TCC GTG CTC GGC GAT GGA CCA GA 
OSCAR 
Sense: CTG CTG GTA ACG GAT CAG CTC CCC AGA 
Antisense: CCA AGG AGC CAG AAC CTT CGA AAC 
NFATc1 
Sense: CTC GAA AGA CAG CAC TGG AGC AT 
Antisense: CGG CTG CCT TCC GTC TCA TAG 
c-FOS 
Sense: CTG GTG CAG CCC ACT CTG GTC 
Antisense: CTT TCA GCA GAT TGG CAA TCT C 
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